In May 2018, Ovarian Cancer Australia brought together leading Australian and international researchers, clinicians and industry representatives for a one day independent ovarian cancer symposium for health professionals.
Professor Ursula Matulonis
Presenting on PARP inhibitors: opportunities, challenges and new directions
Professor Clare Scott
Presenting on the role of PARP inhibitors in non-BRCA ovarian cancer
Professor John Zalcberg
Presenting on: the Ovarian Cancer Clinical Quality Registry, its progress and challenges.
Dr George Au-Yeung
Presenting on immunotherapy combinations in high-grade serous ovarian cancer
Dr Tarek Meniawy
Presenting on immunotherapy for ovarian cancer
Dr Dale Garsed
Presenting on 'Surviving ovarian cancer: the role of the immune response'
Dr Olga Kondrashova
Presenting on resistance and sensitivity to PARP inhibition in ovarian cancer
Dr Peter Savas
Presenting on 'Perspectives from breast cancer – immunotherapy and precision oncology'
This event was supported by Astra Zeneca in alliance with the Australia New Zealand Gynaecological Oncology Group (ANZGOG)